141 results
Page 2 of 8
S-4/A
EX-5.1
292k3
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
8-K
EX-10.1
sn7lms 86zj7eb9
11 Apr 23
Adaptimmune and GSK Have Agreed Terms for Transfer of PRAME and NY-ESO Target Programs back to Adaptimmune
8:08am
S-4
tppx9qs2i
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
S-4
4hh38k9r014w2k2
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
8-K
EX-10.1
d4ki02eg
20 Dec 22
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-99.1
5oex2 yomxexlk
4 Aug 22
Adaptimmune Reports Second-Quarter Financial Results and Business Update
7:36am
8-K
ft5qn
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
8-K
EX-10.1
mcia w445
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
424B5
k8xz7
28 Apr 22
Prospectus supplement for primary offering
8:09am
8-K
EX-10.01
cmhrfu2
26 Jan 22
Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer
8:05am